T1	CHEM 82 92	ESTRÓGENOS
#1	AnnotatorNotes T1	C0014939; estrogens; Hormone · Organic Chemical · Pharmacologic Substance
T2	CHEM 95 110	ANTICONCEPTIVOS
#2	AnnotatorNotes T2	C0009871; Contraceptive Agents; Pharmacologic Substance
T3	DISO 556 571	factor tubárico
#3	AnnotatorNotes T3	C0745287; infertility tubal factor; Disease or Syndrome
T4	PROC 135 144	PROTOCOLO
#4	AnnotatorNotes T4	C0008971; Clinical Protocols; Therapeutic or Preventive Procedure
T5	PROC 200 211	TRATAMIENTO
#5	AnnotatorNotes T5	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T6	DISO 235 246	Esterilidad
#6	AnnotatorNotes T6	C0021359; Infertility; Pathologic Function | C0917730; Female sterility; Finding | C4074771; Sterility, Reproductive; Pathologic Function
T7	PROC 363 383	tratamiento FIV-ICSI
#7	AnnotatorNotes T7	C1960384; IVF - In vitro fertilization with intracytoplasmic sperm injection (ICSI); Therapeutic or Preventive Procedure
T8	PROC 388 397	protocolo
#8	AnnotatorNotes T8	C0008971; Clinical Protocols; Therapeutic or Preventive Procedure
T9	PROC 401 421	estimulación ovárica
T10	DISO 599 619	baja reserva ovárica
T11	DISO 485 496	esterilidad
#9	AnnotatorNotes T11	C0021359; Infertility; Pathologic Function | C0917730; Female sterility; Finding | C4074771; Sterility, Reproductive; Pathologic Function
T12	DISO 573 586	endometriosis
#10	AnnotatorNotes T12	C0014175; Endometriosis; Disease or Syndrome
T13	DISO 622 633	esterilidad
#11	AnnotatorNotes T13	C0021359; Infertility; Pathologic Function | C0917730; Female sterility; Finding | C4074771; Sterility, Reproductive; Pathologic Function
T14	PROC 814 832	valores hormonales
T15	CHEM 822 832	hormonales
#12	AnnotatorNotes T15	C0019932; Hormones; Hormone
T16	PROC 864 867	FSH
#13	AnnotatorNotes T16	C0202022; Follicle stimulating hormone measurement; Laboratory Procedure
T17	PROC 931 955	consentimiento informado
#14	AnnotatorNotes T17	C0567423; Informed consent for procedure; Therapeutic or Preventive Procedure
T18	PROC 789 797	FIV-ICSI
T19	ANAT 972 985	ambos ovarios
#15	AnnotatorNotes T19	C0227898; Both ovaries; Body Part, Organ, or Organ Component
T20	ANAT 1052 1063	endometrial
#16	AnnotatorNotes T20	C0014180; Endometrium; Body Part, Organ, or Organ Component | C1269566; Entire endometrium; Body Part, Organ, or Organ Component
T21	DISO 1066 1086	malformación uterina
T22	PROC 1087 1100	diagnosticada
#17	AnnotatorNotes T22	C0011900; Diagnosis; Diagnostic Procedure
T23	DISO 1013 1026	Endometriosis
#18	AnnotatorNotes T23	C0014175; Endometriosis; Disease or Syndrome
T24	DISO 1115 1146	Síndrome de ovario poliquístico
#19	AnnotatorNotes T24	C0032460; Polycystic Ovary Syndrome; Disease or Syndrome
T25	PROC 1220 1230	extirpados
#20	AnnotatorNotes T25	C0728940; Excision; Therapeutic or Preventive Procedure
T26	DISO 1248 1255	alergia
#21	AnnotatorNotes T26	C1527304; Allergic Reaction; Pathologic Function
T27	CHEM 1272 1280	fármacos
#22	AnnotatorNotes T27	C0013227; Pharmaceutical Preparations; Pharmacologic Substance | C0456386; Medicament; Pharmacologic Substance
T28	ANAT 1324 1329	semen
#23	AnnotatorNotes T28	C0036614; Seminal fluid; Body Substance | C2756969; Semen; Body Substance
T29	PROC 1333 1351	biopsia testicular
#24	AnnotatorNotes T29	C0403215; Biopsy of testis; Diagnostic Procedure
T30	PROC 69 77	FIV-ICSI
T31	DISO 1233 1245	Intolerancia
#25	AnnotatorNotes T31	C0277585; Intolerance to drug; Pathologic Function
T32	ANAT 126 131	LÚTEA
#26	AnnotatorNotes T32	C1280558; Entire corpus luteum of ovary; Tissue
T33	CHEM 149 160	ANTAGONISTA
#27	AnnotatorNotes T33	C4721408; Substance with receptor antagonist mechanism of action (substance); Pharmacologic Substance
T34	ANAT 414 421	ovárica
#28	AnnotatorNotes T34	C0029939; Ovary; Body Part, Organ, or Organ Component | C1278992; Entire ovary; Body Part, Organ, or Organ Component
T35	CHEM 426 449	antagonistas de la GnRH
#29	AnnotatorNotes T35	C1268855; Gonadotropin releasing hormone antagonist; Hormone · Pharmacologic Substance
T36	ANAT 612 619	ovárica
#30	AnnotatorNotes T36	C0029939; Ovary; Body Part, Organ, or Organ Component | C1278992; Entire ovary; Body Part, Organ, or Organ Component
T37	PROC 685 688	IMC
#31	AnnotatorNotes T37	C0005893; Body mass index procedure; Diagnostic Procedure | C3698309; Measurement of body mass index; Health Care Activity
T38	PROC 881 890	estradiol
#32	AnnotatorNotes T38	C0337434; Estradiol measurement; Laboratory Procedure
T39	PROC 1318 1321	REM
#33	AnnotatorNotes T39	C0037842; Sperm Count Procedure; Laboratory Procedure (?) [recuento de espermatozoides móviles]
T40	DISO 1042 1063	Patología endometrial
T41	ANAT 1079 1086	uterina
#34	AnnotatorNotes T41	C0042149; Uterus; Body Part, Organ, or Organ Component | C1269032; Entire uterus; Body Part, Organ, or Organ Component
T42	ANAT 1127 1133	ovario
#35	AnnotatorNotes T42	C0029939; Ovary; Body Part, Organ, or Organ Component | C1278992; Entire ovary; Body Part, Organ, or Organ Component
T43	ANAT 1341 1351	testicular
#36	AnnotatorNotes T43	C0039597; Testis; Body Part, Organ, or Organ Component | C1278981; Entire testis; Body Part, Organ, or Organ Component | C1284096; Entire testicle; Body Part, Organ, or Organ Component
T44	DISO 1354 1376	oligoastenozoospermias
#37	AnnotatorNotes T44	C3164407; Oligoasthenozoospermia; Disease or Syndrome
T45	DISO 1204 1216	hidrosálpinx
#38	AnnotatorNotes T45	C0221376; Hydrosalpinx (disease); Disease or Syndrome
T46	Date 13 17	2014
T47	Route 111 117	ORALES
#39	AnnotatorNotes T47	C1527415; Oral Route of Drug administration; Functional Concept
T48	Neg_cue 197 199	NO
T50	LIVB 452 461	Pacientes
#40	AnnotatorNotes T50	C0030705; Patients; Patient or Disabled Group
T51	Age 462 480	entre 18 y 40 años
T52	PHYS 604 619	reserva ovárica
#41	AnnotatorNotes T52	C3850153; Ovarian Reserve; Organ or Tissue Function
T53	LIVB 668 677	Pacientes
#42	AnnotatorNotes T53	C0030705; Patients; Patient or Disabled Group
T54	Frequency 744 759	cada 26-35 días
T55	LIVB 800 809	Pacientes
#43	AnnotatorNotes T55	C0030705; Patients; Patient or Disabled Group
T56	Date 841 850	el 3º día
T57	LIVB 905 914	Pacientes
#44	AnnotatorNotes T57	C0030705; Patients; Patient or Disabled Group
T59	Neg_cue 1217 1219	no
T60	PHYS 121 131	FASE LÚTEA
#45	AnnotatorNotes T60	C0024153; Luteal Phase; Organ or Tissue Function
T49	LIVB 275 284	Pacientes
#46	AnnotatorNotes T49	C0030705; Patients; Patient or Disabled Group
T61	PHYS 714 732	ciclos ovulatorios
#47	AnnotatorNotes T61	C0205836; Ovarian Cycle; Physiologic Function
T58	DISO 538 554	factor masculino
#48	AnnotatorNotes T58	C2910719; Encounter for male factor infertility in female patient; Finding [ICD-10: Z31.81]
T62	DISO 1283 1299	Factor masculino
#49	AnnotatorNotes T62	C2910719; Encounter for male factor infertility in female patient; Finding [ICD-10: Z31.81]
A1	Assertion T5 Negated
A2	Assertion T25 Negated
A3	Status T40 History_of
A4	Status T21 History_of
A5	Status T26 History_of
A6	Status T31 History_of
A7	Status T11 History_of
#50	AnnotatorNotes T30	C1960384; IVF - In vitro fertilization with intracytoplasmic sperm injection (ICSI); Therapeutic or Preventive Procedure
#51	AnnotatorNotes T18	C1960384; IVF - In vitro fertilization with intracytoplasmic sperm injection (ICSI); Therapeutic or Preventive Procedure
#52	AnnotatorNotes T9	C0949385; Ovarian Stimulation; Therapeutic or Preventive Procedure
#53	AnnotatorNotes T21	C0266383; Uterine Anomalies; Congenital Abnormality 
T63	CONC 646 652	origen
A8	Assertion T63 Speculated
T64	Spec_cue 653 664	desconocido
R1	Speculation Arg1:T64 Arg2:T63	
T65	Quantifier_or_Qualifier 778 788	< 3 ciclos
R2	Has_Quantifier_or_Qualifier Arg1:T18 Arg2:T65	
T66	Result_or_Value 689 698	< 30Kg/m2
R3	Has_Result_or_Value Arg1:T37 Arg2:T66	
R4	Experiences Arg1:T53 Arg2:T37	
R5	Has_Frequency Arg1:T61 Arg2:T54	
T67	Quantifier_or_Qualifier 733 742	regulares
#54	AnnotatorNotes T67	C0205272; Regular; Qualitative Concept
R6	Has_Quantifier_or_Qualifier Arg1:T61 Arg2:T67	
R7	Used_for Arg1:T1 Arg2:T30	
R8	Used_for Arg1:T2 Arg2:T30	
R9	Has_Route_or_Mode Arg1:T2 Arg2:T47	
R10	Location_of Arg1:T32 Arg2:T60	
R11	Overlap Arg1:T2 Arg2:T60	
R12	Overlap Arg1:T1 Arg2:T60	
R13	Combined_with Arg1:T2 Arg2:T33	
R14	Combined_with Arg1:T1 Arg2:T33	
R15	Negation Arg1:T48 Arg2:T5	
R16	Experiences Arg1:T49 Arg2:T7	
R17	Combined_with Arg1:T7 Arg2:T9	
R18	Location_of Arg1:T34 Arg2:T9	
R19	Used_for Arg1:T35 Arg2:T9	
R20	Has_Age Arg1:T50 Arg2:T51	
T68	Quantifier_or_Qualifier 497 505	primaria
#55	AnnotatorNotes T68	C0205225; Primary; Qualitative Concept
R21	Has_Quantifier_or_Qualifier Arg1:T11 Arg2:T68	
A9	Status T68 History_of
R22	Experiences Arg1:T50 Arg2:T11	
R23	Causes Arg1:T58 Arg2:T11	
R24	Causes Arg1:T3 Arg2:T11	
R25	Causes Arg1:T12 Arg2:T11	
T69	Quantifier_or_Qualifier 587 597	grado I-II
R26	Has_Quantifier_or_Qualifier Arg1:T12 Arg2:T69	
R27	Causes Arg1:T10 Arg2:T11	
R29	Location_of Arg1:T36 Arg2:T52	
R30	Location_of Arg1:T36 Arg2:T10	
#56	AnnotatorNotes T10	C3839507; Diminished ovarian reserve; Disease or Syndrome
T70	Quantifier_or_Qualifier 634 642	primaria
#57	AnnotatorNotes T70	C0205225; Primary; Qualitative Concept
R31	Has_Quantifier_or_Qualifier Arg1:T13 Arg2:T70	
R32	Experiences Arg1:T50 Arg2:T10	
R33	Experiences Arg1:T50 Arg2:T13	
T71	Quantifier_or_Qualifier 643 664	de origen desconocido
#58	AnnotatorNotes T71	C0332240; Unknown (origin) (qualifier value); Functional Concept
R34	Has_Quantifier_or_Qualifier Arg1:T13 Arg2:T71	
R35	Experiences Arg1:T55 Arg2:T14	
R36	Overlap Arg1:T14 Arg2:T56	
T72	Result_or_Value 868 878	< 14 IU/ml
T73	Result_or_Value 891 901	< 80 pg/ml
R38	Has_Result_or_Value Arg1:T38 Arg2:T73	
R39	Overlap Arg1:T16 Arg2:T56	
T74	Quantifier_or_Qualifier 833 840	basales
#59	AnnotatorNotes T74	C1442488; Baseline; Quantitative Concept
R41	Has_Quantifier_or_Qualifier Arg1:T14 Arg2:T74	
T75	Quantifier_or_Qualifier 1027 1039	grado III-IV
R43	Has_Quantifier_or_Qualifier Arg1:T23 Arg2:T75	
R44	Location_of Arg1:T20 Arg2:T40	
R45	Location_of Arg1:T41 Arg2:T21	
#60	AnnotatorNotes T40	C1720816; Endometrial Diseases; Disease or Syndrome
R46	Location_of Arg1:T42 Arg2:T24	
R47	Negation Arg1:T59 Arg2:T25	
R48	Causes Arg1:T27 Arg2:T26	
R49	Causes Arg1:T27 Arg2:T31	
T76	Result_or_Value 1308 1317	< 100.000
R50	Has_Result_or_Value Arg1:T39 Arg2:T76	
R51	Location_of Arg1:T43 Arg2:T29	
T77	Quantifier_or_Qualifier 1300 1306	severo
#61	AnnotatorNotes T77	C1547227; Severe -Severity of Illness Code; Intellectual Product
R52	Has_Quantifier_or_Qualifier Arg1:T62 Arg2:T77	
T78	Quantifier_or_Qualifier 1377 1384	severas
#62	AnnotatorNotes T78	C1547227; Severe -Severity of Illness Code; Intellectual Product
R53	Has_Quantifier_or_Qualifier Arg1:T44 Arg2:T78	
#63	AnnotatorNotes T63	C0015127; Etiology aspects; Functional Concept | C1314792; Etiology; Functional Concept
T79	CONC 1166 1188	criterios de Rotterdam
#64	AnnotatorNotes T69	C0444502; First degree; Qualitative Concept | C0443298; Second degree; Qualitative Concept
R28	Experiences Arg1:T50 Arg2:T52	
R57	Experiences Arg1:T50 Arg2:T58	
R58	Experiences Arg1:T50 Arg2:T3	
R59	Experiences Arg1:T50 Arg2:T12	
#65	AnnotatorNotes T14	C0441683; Hormone measurement; Laboratory Procedure
R40	Has_Result_or_Value Arg1:T16 Arg2:T72	
R42	Overlap Arg1:T38 Arg2:T56	
A10	Experiencer T53 Patient
A11	Experiencer T55 Patient
A12	Experiencer T57 Patient
A13	Experiencer T49 Patient
A14	Experiencer T50 Patient
